Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

2.48
Data as of Jan 27
 +0.12 / +5.08%
Today’s Change
1.46
Today|||52-Week Range
3.79
+56.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income-17.3K-80.0K-331.0K-353.0K
 
 
 
 
 
Total Operating Expenses35.8M93.1M55.9M28.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.8M-93.1M-55.9M-28.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-40.4M-95.3M-59.4M-30.9M
 
 
 
 
 
Net Income-40.4M-95.3M-59.4M-30.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.9M4.7M7.2M18.3M
 
 
 
 
 
Shares To Calculate EPS Diluted2.9M4.7M7.2M18.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$14.08-$20.40-$8.24-$1.69
 
 
 
 
 
EPS Diluted----------
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.